|
SLC35D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62625468647093E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.35922392732846E-13 |
| Normal-vs-Stage2 |
3.04319999999692E-06 |
| Normal-vs-Stage3 |
1.32219790671684E-11 |
| Normal-vs-Stage4 |
5.96890314952248E-11 |
| Stage1-vs-Stage2 |
5.316200E-01 |
| Stage1-vs-Stage3 |
2.885600E-01 |
| Stage1-vs-Stage4 |
1.087770E-01 |
| Stage2-vs-Stage3 |
2.273200E-01 |
| Stage2-vs-Stage4 |
9.218000E-02 |
| Stage3-vs-Stage4 |
4.891200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.07371922253697E-14 |
| Normal-vs-AfricanAmerican |
5.438800E-04 |
| Normal-vs-Asian |
3.90219967449923E-10 |
| Caucasian-vs-AfricanAmerican |
1.755560E-01 |
| Caucasian-vs-Asian |
3.046400E-01 |
| AfricanAmerican-vs-Asian |
3.664200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.53761505936745E-13 |
| Normal-vs-Female |
1.67688085639384E-12 |
| Male-vs-Female |
3.162800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.60080845748689E-12 |
| Normal-vs-Age(41-60Yrs) |
1.85069737312915E-11 |
| Normal-vs-Age(61-80Yrs) |
1.04950492740841E-11 |
| Normal-vs-Age(81-100Yrs) |
2.575700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.986000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.064400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.795600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.899800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.560400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.203000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.300380E-01 |
| Classical-VS-Follicular |
9.083000E-01 |
| Classical-VS-Other |
3.140200E-01 |
| Classical-VS-Normal |
1.73316916374233E-12 |
| Tall-VS-Follicular |
1.746630E-01 |
| Tall-VS-Other |
8.050200E-01 |
| Tall-VS-Normal |
1.01520003514821E-09 |
| Follicular-VS-Other |
4.408400E-01 |
| Follicular-VS-Normal |
4.04429999489864E-08 |
| Other-VS-Normal |
1.123400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.14308562615406E-12 |
| Normal-vs-N1 |
4.47559767025041E-11 |
| N0-vs-N1 |
8.624300E-02 |
|
|
